Connect your AI

Inogen INGN Change in Deferred Revenue

Change in Deferred Revenue at other companies

Viemed Healthcare, Inc.VMD

-$41K-141%

Pulmonx CorporationLUNG

$14K+275%

iRhythm Holdings, Inc. IRTC

-$145K-141%

Other financials

Income statement

Revenue$85.1M+3.4%

Gross profit$44.9M+1.7%

Operating income-$9.3M-21.9%

Net income-$8.3M-34.8%

EPS (diluted)-$0.30-20.0%

Balance sheet

Cash & equivalents$93.1M-21.7%

Total debt$16.9M-11.9%

Total equity$182.9M-7.6%

Total assets$285.9M-7.3%

Cash flow

Operating cash flow-$6.7M+60.2%

CapEx$210.0K-28.1%

Free cash flow-$6.9M+59.6%

Valuation

Market cap$174.63M-9.7%

Enterprise value$98.45M-9.5%

P/S0.5×-0.1×

Profitability

Gross margin52.8%-2.6pp

Operating margin-9.1%-0.8pp

Net margin-7.1%-0.8pp

FCF margin0.4%—

Returns & leverage

Return on equity-13.1%-0.9pp

Debt / equity0.1×0.0×

Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Inogen's change in deferred revenue?: Inogen (INGN) reported change in deferred revenue of -$846K in Q1 2026.
How has Inogen's change in deferred revenue changed year-over-year?: Inogen's change in deferred revenue increased by 4.3% year-over-year, from -$884K to -$846K.
What is the long-term trend for Inogen's change in deferred revenue?: Over 3 years (2021 to 2025), Inogen's change in deferred revenue has grown at a 23.6% compound annual growth rate (CAGR), from $1.74M to -$3.3M.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.